LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
Dr. Aaron Kovaleski, a renowned expert in endovascular interventions, has conducted research on the use of the Auryon atherectomy system for PAD interventions. Peripheral artery disease is a common ...
Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee Blockages LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (ANGO), a medical technology company focused ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, ...
(RTTNews) - AngioDynamics, Inc. (ANGO) announced on Tuesday that it has received FDA 510(k) clearance for the Auryon XL Catheter, a 225-cm radial access catheter designed for use with the Auryon ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN
AngioDynamics targets 14%-16% MedTech growth for fiscal 2025 driven by thrombectomy and NanoKnife adoption
CEO Jim Clemmer highlighted strong Q3 performance with total revenue reaching $72 million, reflecting over 9% year-over-year growth. MedTech revenue grew by 22%, with continued success across ...
Trial Evaluates Effectiveness of Innovative Auryon Atherectomy System in Complex Below-the-Knee Cases LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (ANGO), a leading and transformative medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results